DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on February 4, 2021, covering events that occurred on February 1, 2021. DarioHealth Corp. (DRIO), an emerging growth company incorporated in Delaware, reported the completion of a strategic acquisition and a key executive appointment.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses on corporate events rather than periodic financial performance.
Material Changes
- Acquisition of Upright Technologies Ltd.: The Company acquired all outstanding securities of Upright Technologies Ltd. through its subsidiary, LabStyle Innovation Ltd.
- Consideration: The Company agreed to issue 1,687,612 shares of common stock to Upright security holders and assume options to purchase up to 100,193 shares of common stock, subject to escrow and indemnity provisions.
- Executive Appointment: Oded Cohen was hired as General Manager of Musculoskeletal (MSK) effective February 1, 2021.
Management Commentary, Risks, and Unusual Items
Compensatory Arrangements: Mr. Cohen's employment agreement includes a monthly salary of NIS 63,000 and an annual bonus of up to four times his monthly salary. He is eligible for restricted stock unit (RSU) awards totaling up to 220,980 shares (73,660 shares initially, with two additional tranches of 73,660 shares each contingent on meeting milestones in 2022 and 2023).
Regulation FD Disclosure: The Company attached an investor presentation (Exhibit 99.1) for use in investor meetings. The Company explicitly states it undertakes no obligation to update or amend this material, and it is not deemed "filed" for liability purposes under the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the exact number of shares issued (1,687,612) and options assumed (100,193) for the Upright Technologies acquisition.
- Review the specific milestones required for Mr. Cohen to receive the additional RSU tranches in 2022 and 2023.
- Examine the full text of the Employment Agreement (Exhibit 10.1) for detailed non-competition and severance terms.
- Assess the strategic fit of Upright Technologies' assets with DarioHealth's existing musculoskeletal portfolio.